Free Trial
→ Nvidia’s CEO: “This Will Be a Multitrillion-Dollar Industry.' (From Brownstone Research) (Ad) Free XLO Stock Alerts

Xilio Therapeutics (XLO) Institutional Ownership

Xilio Therapeutics logo
$0.93 -0.13 (-12.26%)
Closing price 02/21/2025 04:00 PM Eastern
Extended Trading
$0.93 0.00 (-0.11%)
As of 02/21/2025 08:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

Institutional Ownership Changes (13F Filings) for Xilio Therapeutics (NASDAQ:XLO)

Current
Institutional Ownership
Percentage
54.29%
Number of
Institutional Buyers
(last 12 months)
10
Total
Institutional Inflows
(last 12 months)
$10.82M
Number of
Institutional Sellers
(last 12 months)
1
Total
Institutional Outflows
(last 12 months)
$1.91M
Get XLO Insider Trade Alerts

Want to know when executives and insiders are buying or selling Xilio Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

XLO Institutional Buying and Selling by Quarter

Xilio Therapeutics Major Shareholders & Ownership History

Export to Excel
Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
2/17/2025 Trustees of Columbia University in the City of New York249,635$238K0.0%N/A0.568%
2/17/2025 Balyasny Asset Management L.P.343,230$328K0.0%+26.0%0.781%
2/17/2025 Aptus Capital Advisors LLC41,000$39K0.0%N/A0.093%
2/14/2025 Gilead Sciences Inc.9,105,451$8.70M0.6%N/A20.713%
2/13/2025 Raymond James Financial Inc.50,086$48K0.0%N/A0.114%
2/13/2025 Renaissance Technologies LLC296,617$283K0.0%+11.4%0.675%
2/12/2025 Geode Capital Management LLC358,422$342K0.0%+6.0%0.815%
2/12/2025 Takeda Pharmaceutical Co. Ltd.1,475,121$1.42M5.3%N/A3.356%
2/6/2025 Raymond James Financial Inc.50,086$48K0.0%N/A0.114%
11/16/2024 Geode Capital Management LLC338,192$266K0.0%+85.0%0.769%
8/12/2024 XTX Topco Ltd33,289$32K0.0%N/A0.076%
8/9/2024 Renaissance Technologies LLC295,000$280K0.0%+18.3%0.799%
5/6/2024 Atlas Venture Life Science Advisors LLC992,912$1.07M0.1%-64.0%2.690%
4/22/2024 PFG Investments LLC30,000$32K0.0%N/A0.087%
2/15/2024 Octagon Capital Advisors LP1,785,000$982K0.2%-23.0%6.481%
11/14/2022Ergoteles LLC12,941$38K0.0%-26.3%0.047%
8/15/2022 Laurion Capital Management LP142,900$417K0.0%N/A0.520%
7/27/2022 Bailard Inc.36,632$107K0.0%N/A0.133%
5/16/2022 Deerfield Management Company L.P. Series C2,078,692$14.70M0.3%-3.5%7.567%
5/12/2022 Monashee Investment Management LLC163,066$1.15M0.3%-23.9%0.594%
2/15/2022 Davidson Kempner Capital Management LP29,000$458K0.0%N/A0.109%
2/14/2022 Deerfield Management Company L.P. Series C2,154,061$33.74M0.7%N/A8.078%
2/14/2022 Ghisallo Capital Management LLC30,000$480K0.0%N/A0.113%
2/14/2022 Soleus Capital Management L.P.477,495$7.64M0.8%N/A1.791%
2/11/2022Granite Point Capital Management L.P.10,000$160K0.0%N/A0.038%
2/9/2022AJU IB Investment Co. Ltd.667,742$10.68M14.9%N/A2.504%
2/8/2022 Northern Trust Corp63,034$1.01M0.0%N/A0.236%
2/7/2022 Monashee Investment Management LLC214,253$3.43M0.8%N/A0.803%
2/7/2022RiverVest Venture Management LLC1,441,444$23.06M16.5%N/A5.406%
2/2/2022 New York State Common Retirement Fund5,568$89K0.0%N/A0.021%
(Data available from 1/1/2016 forward)

XLO Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of XLO shares?

During the previous two years, 12 institutional investors and hedge funds held shares of Xilio Therapeutics. The most heavily invested institutionals were Gilead Sciences Inc. ($8.70M), Takeda Pharmaceutical Co. Ltd. ($1.42M), Atlas Venture Life Science Advisors LLC ($1.07M), Octagon Capital Advisors LP ($982K), Geode Capital Management LLC ($342K), Balyasny Asset Management L.P. ($328K), and Renaissance Technologies LLC ($283K).Learn more on XLO's institutional investors.

What percentage of Xilio Therapeutics stock is owned by institutional investors?

54.29% of Xilio Therapeutics stock is owned by institutional investors. Learn more on XLO's institutional investor holdings.

Which institutional investors have been buying Xilio Therapeutics stock?

Of the 10 institutional investors that purchased Xilio Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Gilead Sciences Inc. ($9.11M), Takeda Pharmaceutical Co. Ltd. ($1.48M), Trustees of Columbia University in the City of New York ($249.64K), Geode Capital Management LLC ($175.57K), Raymond James Financial Inc. ($100.17K), Renaissance Technologies LLC ($75.87K), and Balyasny Asset Management L.P. ($70.74K).

How much institutional buying is happening at Xilio Therapeutics?

Institutional investors have bought a total of 11,356,850 shares in the last 24 months. This purchase volume represents approximately $10.82M in transactions.

Which Xilio Therapeutics major shareholders have been selling company stock?

The following institutional investors have sold Xilio Therapeutics stock in the last 24 months: Atlas Venture Life Science Advisors LLC ($1.77M), and Octagon Capital Advisors LP ($533.50K).

How much institutional selling is happening at Xilio Therapeutics?

Institutional investors have sold a total of 2,299,932 shares in the last 24 months. This volume of shares sold represents approximately $2.20M in transactions.


Related Companies

This page (NASDAQ:XLO) was last updated on 2/22/2025 by MarketBeat.com Staff
From Our Partners
Secret financial plot unfolding in Washington DC… [DEVELOPING]
What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...
Timothy Sykes | Sponsored
Buy this AI Stock Before Elon’s Announcement
With Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...
InvestorPlace | Sponsored
[RFK Jr CONFIRMED] Here’s why Dems are TERRIFIED
Robert F. Kennedy Jr was just confirmed as Trump’s secretary of Health and Human Services… but it was NOT easy...
NewMarket Health Publishing, LLC. | Sponsored
Elon’s “New Gold”
MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...
True Market Insiders | Sponsored
Grab This Altcoin Before Trump's Crypto Announcement
Grab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which ...
Crypto 101 Media | Sponsored
Why Buffett and 100 members of Congress are Piling into this One Investment
This isn't just another investment. It might be the last retirement stock you'll ever need. But this win...
Behind the Markets | Sponsored
Market down? Do this now.
During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...
Colonial Metals | Sponsored
Collect $7k per month from Tesla’s SECRET dividend
Tesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...
Investors Alley | Sponsored